In recent years, China's medical device industry has achieved leapfrog development, the market size has exceeded 1.2 trillion yuan, with an annual growth rate of more than 15%. In the national policy support and market demand driven by the double, the industry is accelerating from "Made in China" to "China Smart" transformation.
Policy dividends continue to release, the "14th Five-Year Plan" medical equipment, "clearly required to increase the localization rate, county hospitals in the high-end domestic equipment accounted for 70%. Significant technological breakthroughs, joint shadow medical, medical and other leading enterprises have successfully developed 3.0T MRI, 256 row CT and other high-end equipment, AI-assisted diagnostic system to achieve commercialization of landing.
The market pattern presents two characteristics: on the one hand, domestic equipment with low-cost advantage to quickly replace imported products; on the other hand, the head of the enterprise to accelerate the sea, 2024 exports increased by 28% year on year. Myriad Medical and other companies have successfully entered the high-end market in Europe and the United States.
Looking ahead, the industry still faces challenges such as dependence on imports of core components, but with increased investment in R & D and the "Belt and Road" market development, China's medical equipment enterprises are expected to occupy a more important position in the global value chain. For investors, high-end imaging equipment, surgical robots and other segments hold huge business opportunities.
